Physician profile
Ryan DO Falbo
NPI 1184185993
$28,863.24
in general payments reported to CMS, 2019-2025
12 companies · $3,355 in 2025
The $3,355 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $370 · 2022: $4,000 · 2023: $636 · 2024: $20K · 2025: $3,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $2,302 · Food and Beverage: $2,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $2,301.81 |
| Food and Beverage | $2,007.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,014.36 | 2024-2025 | |
| Rock Medical Orthopedics, INC. | $3,716.74 | 2021-2023 | |
| Mid-Atlantic Surgical Systems, LLC | $1,362.02 | 2024-2025 | |
| Stryker Corporation | $586.26 | 2022-2024 | Gamma, T2 Alpha, Variax |
| Smith+Nephew, INC. | $468.06 | 2022-2023 | Panta 2, Bone Anchors With Arthroscopic Delivery System, Rf20000 |
| Integra Lifesciences Corporation | $187.14 | 2021 | |
| Depuy Synthes Sales INC. | $145.11 | 2024 | Tfn-Advance, Na |
| Si-Bone, INC. | $130.07 | 2021 | |
| Cdc Medical LLC | $96.97 | 2019 | |
| Vericel Corporation | $87.24 | 2019 | |
| Zimmer Biomet Holdings, INC. | $52.36 | 2025 | Orthogrid Hip |
| Medtronic, INC. | $16.91 | 2023 | Mazor X System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Falbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.